insights_auto
Why is CLRB up 3.83%?
Dive Deeperchevron_right
CLRB:NASDAQ
Cellectar Biosciences Inc
$1.90
arrow_upward
+3.83%(+0.070) 1D
Sep 29, 12:26:05 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CLRB...
Open
$1.98
High
$1.98
Low
$1.85
Mkt. cap
17.96M
Avg. vol.
49.01K
Volume
66.14K
52-wk high
$6.52
52-wk low
$1.80
EPS
-$4.59
Beta
0.56
Shares outstanding
9.45M
No. of employees
11
Open
$1.98
High
$1.98
Low
$1.85
Mkt. cap
17.96M
Avg. vol.
49.01K
Volume
66.14K
52-wk high
$6.52
52-wk low
$1.80
EPS
-$4.59
Beta
0.56
Shares outstanding
9.45M
No. of employees
11
News stories
From web sources and news partners
Investing News Network
·
4 hours ago
Cellectar Biosciences to Present Compelling Efficacy Data from Phase 2 CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Refractory/Resistant to BTK Inhibitor Therapy at International Workshop for Waldenström Macroglobulinemia
Investing.com Canada
·
5 hours ago
Cellectar plans Phase 3 trial, regulatory filing for WM treatment By Investing.com
Stock Titan
·
5 hours ago
A cancer drug produced responses in 87.5% of patients resistant to a prior cancer treatment
About Cellectar Biosciences Inc
CEO-
Employees11
Founded1996
HeadquartersFlorham Park, New Jersey, United States
SectorBiotechnology
Websitecellectar.com